Meropenem – therapeutic recommendation after twenty years of presence on pharmaceutical market
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2014, Vol 68, Issue
Abstract
Meropenem is the first representative of carbapenem analogues with methyl group, which has been applied in medicine. This drug has been approved by FDA (Food and Drug Administration) in 1996. Available results of clinical trials and scientific reports point surprising synergism of combination of meropenem with other chemotherapeutics, in the treatment of bacterial diseases. Present study based on available information presents indications for use the mentioned antibiotic in pharmacotherapy of infectious diseases. Meropenem is the first representative of carbapenem analogues, which contains methyl group. Introduction of a methyl group at the system of coupled rings: β-lactam and pyrrolidine, solved the problem of degradation by the dehydropeptidase-I (DHP-I). In the consequence it is not necessary to use meropenem in the connection with specific DHP-I inhibitors. Meropenem, similarly to other carbapanem analogues, is intended for the treatment of severe inpatient and outpatient infections. Bacterial resistance to meropenem may be the result of: carbapenemases activity, decreased affinity to Penicillin Binding Proteins - PBP (mainly PBP 2 and PBP 3) and activation of efflux pump (antibiotic ejection outside the cell). Twenty-year period of application of meropenem in pharmacotherapy may cause the spread of methyl-β-lactamases.
Authors and Affiliations
Magdalena Paczkowska, Piotr Garbacki, Przemysław Zalewski, Alicja Talaczyńska, Judyta Cielecka-Piontek
Keywords
Related Articles
- EP ID EP67350
- DOI -
- Views 157
- Downloads 0
Znaczenie metaloproteinaz oraz ich inhibitorów w raku żołądka
Jednym z najistotniejszych etapów rozwoju i przerzutowania nowotworu jest degradacja białek przestrzeni pozakomórkowej (ECM) i błony podstawnej naczyń. Metaloproteinazy (MMPs) należą do enzymów zdolnych do degradacji kol...
Odkrycie neuromedyny U i jej rola w centralnej regulacji homeostazy energetycznej
Neuromedyna U (NMU) jest neuropeptydem o wysoce konserwatywnej strukturze, a jej receptory (NMUR1 i NMUR2) należą do rodziny receptorów związanych z białkami G (GPCR) zaliczanych do grupy tzw. receptorów sierocych. Akty...
Prokaryotic expression systems
For overproduction of recombinant proteins both eukaryotic and prokaryotic expression systems are used. Choosing the right system depends, among other things, on the growth rate and culture of host cells, level of the ta...
Oculomotor disturbances in HIV-positive individuals treated with methadone
Methadone substitution is claimed to be the most effective way of pharmacological management of human immunodeficiency virus (HIV) positive patients addicted to opioids. Possible and clinically the most relevant drug int...
Spożycie ryb a ryzyko wystąpienia raka prostaty
W pracy omówiono zależności między spożyciem ryb, jako surowców bogatych w wielonienasycone długołańcuchowe kwasy tłuszczowe (LC PUFA) omega-3, a ryzykiem wystąpienia nowotworu stercza. Wiele badań naukowych potwierdza k...